NBTX Stock Price | Nanobiotix P/E, Revenue, EPS, & Forecasts

Nanobiotix • NBTX

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Nanobiotix

Ticker

NBTX

Trading on

NASDAQ

ISIN

US63009J1079

Industry

Biotechnology

Sector

Healthcare

CEO

Laurent Levy Ph.D.

Headquarters

60 rue de Wattignies, Paris, undefined, France, 75012

Employees

108

Website

nanobiotix.com

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.

Metrics

BasicAdvanced

Market cap

$230M

P/E ratio

EPS

-$1.70

Dividend Yield

0.00%

Beta

1.56

Forward P/E ratio

48.31

EBIDTA

$-67.7M

Ex dividend date

Price & volume

Market cap

$230M

Average daily volume

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

48.31

PEG ratio

Trailing P/E

Price to sales

3.82

Price to book

65.02

Earnings

EPS

-$1.70

EPS estimate (current quarter)

$0.00

EPS estimate (next quarter)

$0.00

EBITDA

$-67.7M

Revenues (TTM)

$-7.2M

Revenues per share (TTM)

-$0.15

Technicals

Beta

1.56

52-week High

$6.00

52-week Low

$2.76

50-day moving average

$3.62

200-day moving average

$3.91

Short ratio

5.68

Short %

0.18%

Management effectiveness

ROE (TTM)

-198.69%

ROA (TTM)

-52.89%

Profit margin

0.00%

Gross profit margin

$-7.2M

Operating margin

271.42%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

182.10%

Share stats

Outstanding Shares

47.4M

Float

20.6M

Insiders %

Institutions %

12.15%

Analyst Insights & forecasts

75% Buy

25% Hold

0% Sell

Based on information from 4 analysts.

Average price target

$7.45

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.52

-$0.48

-7.46%

Q4 • 20Missed

-$0.52

Q1 • 21Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$9.3M

$-21.9M

-235.46%

Q2 • 24

$-20.9M

$-46.3M

221.36%

Q1 • 25

-324.98%

111.50%

-194.01%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$67.4M

$133M

197.46%

Q4 • 24

$67.4M

$133M

197.46%

Q1 • 25

0.00%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-5.8M

$-2.7M

$-6.3M

Q2 • 24

$-13.7M

$-2.5M

$-14.1M

Q1 • 25

135.01%

-6.59%

122.51%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Nanobiotix share?

Nanobiotix shares are currently traded for undefined per share.

How many shares does Nanobiotix have?

Nanobiotix currently has 47.4M shares.

Does Nanobiotix pay dividends?

No, Nanobiotix doesn't pay dividends.

What is Nanobiotix 52 week high?

Nanobiotix 52 week high is $6.00.

What is Nanobiotix 52 week low?

Nanobiotix 52 week low is $2.76.

What is the 200-day moving average of Nanobiotix?

Nanobiotix 200-day moving average is $3.91.

Who is Nanobiotix CEO?

The CEO of Nanobiotix is Laurent Levy Ph.D..

How many employees Nanobiotix has?

Nanobiotix has 108 employees.

What is the market cap of Nanobiotix?

The market cap of Nanobiotix is $230M.

What is the P/E of Nanobiotix?

The current P/E of Nanobiotix is null.

What is the EPS of Nanobiotix?

The EPS of Nanobiotix is -$1.70.

What is the PEG Ratio of Nanobiotix?

The PEG Ratio of Nanobiotix is null.

What do analysts say about Nanobiotix?

According to the analysts Nanobiotix is considered a buy.